Novel tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia.

Expert Rev Hematol

Division of Hematology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey.

Published: November 2021